336 related articles for article (PubMed ID: 19717810)
1. The cytokine network in chronic obstructive pulmonary disease.
Barnes PJ
Am J Respir Cell Mol Biol; 2009 Dec; 41(6):631-8. PubMed ID: 19717810
[TBL] [Abstract][Full Text] [Related]
2. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
[TBL] [Abstract][Full Text] [Related]
3. Mediators of chronic obstructive pulmonary disease.
Barnes PJ
Pharmacol Rev; 2004 Dec; 56(4):515-48. PubMed ID: 15602009
[TBL] [Abstract][Full Text] [Related]
4. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease.
Donnelly LE; Barnes PJ
Trends Pharmacol Sci; 2006 Oct; 27(10):546-53. PubMed ID: 16911834
[TBL] [Abstract][Full Text] [Related]
5. Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD.
Morjaria JB; Malerba M; Polosa R
Drug Discov Today; 2010 May; 15(9-10):396-405. PubMed ID: 20223295
[TBL] [Abstract][Full Text] [Related]
6. The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma.
Pappas K; Papaioannou AI; Kostikas K; Tzanakis N
Cytokine; 2013 Dec; 64(3):613-25. PubMed ID: 24084332
[TBL] [Abstract][Full Text] [Related]
7. [Role of mediators in the onset of COPD].
Takizawa H
Nihon Rinsho; 2007 Apr; 65(4):623-7. PubMed ID: 17419378
[TBL] [Abstract][Full Text] [Related]
8. New concepts in chronic obstructive pulmonary disease.
Barnes PJ
Annu Rev Med; 2003; 54():113-29. PubMed ID: 12359824
[TBL] [Abstract][Full Text] [Related]
9. Agents against cytokine synthesis or receptors.
Yamagata T; Ichinose M
Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
[TBL] [Abstract][Full Text] [Related]
10. Emerging anti-inflammatory strategies for COPD.
Cazzola M; Page CP; Calzetta L; Matera MG
Eur Respir J; 2012 Sep; 40(3):724-41. PubMed ID: 22496331
[TBL] [Abstract][Full Text] [Related]
11. Understanding the molecular mechanisms of the multifaceted IL-10-mediated anti-inflammatory response: lessons from neutrophils.
Bazzoni F; Tamassia N; Rossato M; Cassatella MA
Eur J Immunol; 2010 Sep; 40(9):2360-8. PubMed ID: 20549669
[TBL] [Abstract][Full Text] [Related]
12. New therapies for chronic obstructive pulmonary disease.
Barnes PJ
Med Princ Pract; 2010; 19(5):330-8. PubMed ID: 20639653
[TBL] [Abstract][Full Text] [Related]
13. Cytokines in chronic obstructive pulmonary disease.
Chung KF
Eur Respir J Suppl; 2001 Dec; 34():50s-59s. PubMed ID: 12392035
[TBL] [Abstract][Full Text] [Related]
14. [Role of inflammation in the etiopathogenesis of COPD].
del Puerto-Nevado L; Pérez-Rial S; Girón-Martínez A; Peces-Barba G
Arch Bronconeumol; 2010 Dec; 46 Suppl 11():2-7. PubMed ID: 21316554
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathogenesis of cigarette smoking-induced stable COPD.
Caramori G; Kirkham P; Barczyk A; Di Stefano A; Adcock I
Ann N Y Acad Sci; 2015 Mar; 1340():55-64. PubMed ID: 25639503
[TBL] [Abstract][Full Text] [Related]
16. The cytokine network in asthma and chronic obstructive pulmonary disease.
Barnes PJ
J Clin Invest; 2008 Nov; 118(11):3546-56. PubMed ID: 18982161
[TBL] [Abstract][Full Text] [Related]
17. Role of interleukin-17F in chronic inflammatory and allergic lung disease.
Hizawa N; Kawaguchi M; Huang SK; Nishimura M
Clin Exp Allergy; 2006 Sep; 36(9):1109-14. PubMed ID: 16961709
[TBL] [Abstract][Full Text] [Related]
18. [Cytokines and proteases involved in pathogenesis of COPD].
Yamaya A; Osanai K
Nihon Rinsho; 2011 Oct; 69(10):1748-53. PubMed ID: 22073567
[TBL] [Abstract][Full Text] [Related]
19. [Implication of oxidant stress in airway inflammation].
Osanai K
Nihon Rinsho; 2003 Dec; 61(12):2119-25. PubMed ID: 14674320
[TBL] [Abstract][Full Text] [Related]
20. Cytokine inhibition in the treatment of COPD.
Caramori G; Adcock IM; Di Stefano A; Chung KF
Int J Chron Obstruct Pulmon Dis; 2014; 9():397-412. PubMed ID: 24812504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
